On #WorldCancerDay we’re proud to be striving towards earlier diagnosis, personalised treatment and better patient care. Together, we can make a difference for people with #cancer

Histofy is delighted to announce the appointment of Professor Nasir Rajpoot as its new Chief Executive Officer 📣  Prof Rajpoot shall continue his duties as CSO and Director whilst taking on this exciting new role! 🚀 linkedin.com/feed/update/ur…

We are excited to announce our partnership with Paige to accelerate the adoption of Histofy AI tools in clinical practice 🤝 histofy.ai/histofy-partne…

Today we took 60 seconds to chat to Yuchang, our Infrastructure Engineer 💬 linkedin.com/feed/update/ur…

Tomorrow, our CEO & CSO Nasir Rajpoot is taking to the stage at Cambridge MedAI Seminars to discuss ‘Interpretable AI for Precision Histopathology’ 🚀

At Histofy, we believe that building transparency into our #AI tools is of paramount importance. Yesterday, our CTO Simon Graham discussed this during his talk at the Digital Pathology & Image Analysis Training School in Vienna 🇦🇹

March is #Colorectal #Cancer Awareness Month. In the UK alone, around 42K new cases of bowel cancer are diagnosed each year, underlining the urgent need for solutions to streamline diagnostics. Histofy is proud to be tackling this challenge head-on 💪 histofy.ai/products-and-s…

Today we caught up with our CEO & CSO, Nasir Rajpoot. Check out what he had to say about his role here at Histofy 💬 linkedin.com/feed/update/ur…

We are proud to be a sponsor of the MIUA2024 conference, taking place in Manchester from 24th-26th July. If you are attending, feel free to connect with us. We would love to chat! miua2024.github.io

We are under a week away from arriving in Vilnius for #ECDP2024! 🇱🇹 If you'll be attending in person, we would love to dive deeper into how our tools can benefit you. Schedule a meeting with us through the link below 👇 calendly.com/histofy/ecdp-2… #digitalpathology

We are proud to announce a partnership with Indica Labs, a leader in AI-powered #pathology image analysis 🤝 The partnership facilitates the integration of #Histofy tools into clinical practice via HALO AP®, placing AI in the hands of pathologists. histofy.ai/histofy-and-in…

We are back after an incredible few days at #ECDP2024 🇱🇹 Thanks so much to everyone who stopped by our booth to chat about our pathology #AI solutions. We look forward to seeing you in Barcelona for #ECDP2025 👋 EuSocDigIntegrPath

📢 News Alert! 🌟 We are thrilled to announce Histofy's new partnership with Lumirares (lumiares.com), a leading healthtech venture capital fund. Read more on the collaboration below 👇 histofy.ai/lumiares-annou…

Histofy announces the formation of its new Scientific Advisory Board of leading experts in the fields of pathology and oncology 📣 Find out more below ⬇️ linkedin.com/posts/histofy_… Ali Khurram Mark Arends

Recently, we caught up with our CMO, David Snead, to chat about his role at Histofy. Check out what he had to say 👇 linkedin.com/posts/histofy_…

Our team are heading to Florence for the 36th European Congress of Pathology and we are looking forward to catching up with experts from across the globe 🇮🇹 🔬 Come and say hello to the team at Booth #51 👋 #Histofy #ECP2024 | European Society of Pathology (ESP)

Are you currently attending the 36th European Congress of Pathology? 🇮🇹 Don’t miss the chance to visit us at booth #51! Meet the #Histofy team and discover how our pioneering AI solutions are transforming #pathology workflows! #pathologyAI #ECP2024

We're back from the beautiful city of Florence after a productive #ECP2024! 🌟 A big thank you to everyone who visited our booth to explore how our AI-powered solutions are transforming #pathology analysis. It was a pleasure connecting with you! histofy.ai